Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

126 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Transcriptional regulation of KCNA2 coding Kv1.2 by EWS::FLI1: involvement in controlling the YAP/Hippo signalling pathway and cell proliferation.
Dupuy M, Postec A, Mullard M, Chantôme A, Hulin P, Brion R, Gueguinou M, Regnier L, Potier-Cartereau M, Brounais-Le Royer B, Baud'huin M, Georges S, Lamoureux F, Ory B, Rédini F, Vandier C, Verrecchia F. Dupuy M, et al. Among authors: verrecchia f. Cell Commun Signal. 2024 Dec 18;22(1):602. doi: 10.1186/s12964-024-01981-4. Cell Commun Signal. 2024. PMID: 39695664 Free PMC article.
Chimeric protein EWS::FLI1 drives cell proliferation in Ewing Sarcoma via aberrant expression of KCNN1/SK1 and dysregulation of calcium signaling.
Dupuy M, Gueguinou M, Postec A, Brion R, Tesfaye R, Mullard M, Regnier L, Amiaud J, Hubsch C, Potier-Cartereau M, Chantôme A, Brounais-Le Royer B, Baud'huin M, Georges S, Lamoureux F, Ory B, Entz-Werlé N, Delattre O, Rédini F, Vandier C, Verrecchia F. Dupuy M, et al. Among authors: verrecchia f. Oncogene. 2025 Jan;44(2):79-91. doi: 10.1038/s41388-024-03199-7. Epub 2024 Nov 1. Oncogene. 2025. PMID: 39487324 Free PMC article.
Prognostic value of hemogram parameters in osteosarcoma: The French OS2006 experience.
Bastard P, Cozic N, Brion R, Gaspar N, Piperno-Neumann S, Cordero C, Leculée-Thébaud E, Gomez-Mascard A, Rédini F, Marchais A, Ikonomova R, Cleirec M, Laurence V, Rigaud C, Abbas R, Verrecchia F, Brugières L, Minard-Colin V. Bastard P, et al. Among authors: verrecchia f. Pediatr Blood Cancer. 2024 Jul;71(7):e31029. doi: 10.1002/pbc.31029. Epub 2024 Apr 28. Pediatr Blood Cancer. 2024. PMID: 38679845
Tetrahydropyridine LIMK inhibitors: Structure activity studies and biological characterization.
Champiré A, Berabez R, Braka A, Cosson A, Corret J, Girardin C, Serrano A, Aci-Sèche S, Bonnet P, Josselin B, Brindeau P, Ruchaud S, Leguevel R, Chatterjee D, Mathea S, Knapp S, Brion R, Verrecchia F, Vallée B, Plé K, Bénédetti H, Routier S. Champiré A, et al. Among authors: verrecchia f. Eur J Med Chem. 2024 May 5;271:116391. doi: 10.1016/j.ejmech.2024.116391. Epub 2024 Apr 9. Eur J Med Chem. 2024. PMID: 38669909 Free article.
Super-enhancers: drivers of cells' identities and cells' debacles.
Lavaud M, Tesfaye R, Lassous L, Brounais B, Baud'huin M, Verrecchia F, Lamoureux F, Georges S, Ory B. Lavaud M, et al. Among authors: verrecchia f. Epigenomics. 2024 Apr 8;16(9):681-700. doi: 10.2217/epi-2023-0409. Online ahead of print. Epigenomics. 2024. PMID: 38587919 Review.
Ewing sarcoma from molecular biology to the clinic.
Dupuy M, Lamoureux F, Mullard M, Postec A, Regnier L, Baud'huin M, Georges S, Brounais-Le Royer B, Ory B, Rédini F, Verrecchia F. Dupuy M, et al. Among authors: verrecchia f. Front Cell Dev Biol. 2023 Sep 11;11:1248753. doi: 10.3389/fcell.2023.1248753. eCollection 2023. Front Cell Dev Biol. 2023. PMID: 37752913 Free PMC article. Review.
SKCa- and Kv1-type potassium channels and cancer: Promising therapeutic targets?
Dupuy M, Gueguinou M, Potier-Cartereau M, Lézot F, Papin M, Chantôme A, Rédini F, Vandier C, Verrecchia F. Dupuy M, et al. Among authors: verrecchia f. Biochem Pharmacol. 2023 Oct;216:115774. doi: 10.1016/j.bcp.2023.115774. Epub 2023 Sep 5. Biochem Pharmacol. 2023. PMID: 37678626 Free article. Review.
Tracking Targets of Dynamic Super-Enhancers in Vitro to Better Characterize Osteoclastogenesis and to Evaluate the Effect of Diuron on the Maturation of Human Bone Cells.
Tesfaye RA, Lavaud M, Charrier C, Brounais-Le Royer B, Cartron PF, Verrecchia F, Baud'huin M, Lamoureux F, Georges S, Ory B. Tesfaye RA, et al. Among authors: verrecchia f. Environ Health Perspect. 2023 Jun;131(6):67007. doi: 10.1289/EHP11690. Epub 2023 Jun 12. Environ Health Perspect. 2023. PMID: 37307168 Free PMC article.
126 results